A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae.

The Journal of antimicrobial chemotherapy

Volumn 62 Suppl 1, Issue , 2008, Pages

  Vasilev, Krasimir ^a   Reshedko, Galina ^a   Orasan, Remus ^a   Sanchez, Miguel ^a   Teras, Juri ^a   Babinchak, Tim ^a   Dukart, Gary ^a   Cooper, Angel ^a   Dartois, Nathalie ^a   Gandjini, Hassan ^a   Orrico, Russ ^a   Ellis Grosse, Evelyn ^a  

^a MILITARY MEDICAL ACADEMY   (Bulgaria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; DRUG DERIVATIVE; MINOCYCLINE; TIGECYCLINE;

ACINETOBACTER BAUMANNII; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; CLINICAL TRIAL; DRUG EFFECT; ENTEROBACTER; ENTEROBACTER INFECTION; FEMALE; HOSPITALIZATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KLEBSIELLA PNEUMONIAE; MALE; MICROBIOLOGY; MIDDLE AGED; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; TREATMENT OUTCOME;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADULT; AGED; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; ENTEROBACTER; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HOSPITALIZATION; HUMANS; INJECTIONS, INTRAVENOUS; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED; MINOCYCLINE; TREATMENT OUTCOME;

EID: 54049101716     PISSN: None     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkn249     Document Type: Article

References (0)